Biocon Biologics is well-placed to take advantage of opportunities in the biosimilars space: CEO 2023-08-14T05:29:15-04:00August 14th, 2023| share this article! Shreehas Tambe of Biocon Biologics discusses why he is optimistic about the prospects for the company. Read More share this article! Related Posts Shein in discussions about London IPO, UK minister says May 20th, 2024 Games Global files to withdraw U.S. IPO plans May 13th, 2024 Hopefully by 2025 the IPO market is ‘back to normal’, says JPMorgan’s Jennifer Nason May 8th, 2024 Viking CEO: We are very different from big cruise lines May 1st, 2024
